United States Últimas notícias

AbbVie (NYSE:ABBV) reported positive Phase 3 LUNA trial topline results for atogepant, showing reduced migraine days in women with menstrual migraine.

Leonardo DRS (NYSE:DRS) received contracts totaling $96 million to supply critical electronics hardware for the U.S. Navy’s MK 41 Vertical Launching System used on naval vessels.

American Industrial Technologies (SIMA) expects approximately $45 million in consolidated revenue for the third quarter of 2026, including contributions from its existing businesses and expanded international platform.

Kenvue (NYSE:KVUE) announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock.

Bending Spoons (NASDAQ:BSP) entered an agreement to acquire Miro at an enterprise value of $1.355 billion, with the transaction expected to expand its software product portfolio.

Mexico Ambassador to the United States Roberto Lazzeri discusses trade talks between the US and Mexico, saying the two sides are "pretty much aligned with the overall objective." He speaks on "Bloomberg Surveillance."

CAMP4 Therapeutics (NASDAQ:CAMP) received authorization from the UK Medicines and Healthcare products Regulatory Agency to include United Kingdom sites in its planned global Phase 1/2 clinical trial of CMP-002 for SYNGAP1-related disorder.

CervoMed (NASDAQ:CRVO) announced that neflamapimod will be featured in a late-breaking oral presentation at the International Society of Frontotemporal Dementias Annual Meeting in October 2026.

MasterCraft Boat Holdings (NASDAQ:MCFT) reported fiscal fourth-quarter 2026 net sales of $129.9 million, up $50.4 million or 63.4% year over year.

Kurt Reiman, head of fixed income at UBS Global Wealth Management, says multiple factors and "definitely not just the deficit" are pushing bond yields higher and explains why he expects two interest-rate hikes from the Federal Reserve this year.

Burning Rock Biotech (NASDAQ:BNR) reported second-quarter 2026 revenue of RMB134.7 million, down 9.3% year over year, with net loss increasing to RMB18.4 million.

The Lovesac Company (NASDAQ:LOVE) reported second-quarter fiscal 2027 net sales of $161.2 million, up 0.4% year over year, and returned to quarterly profitability with net income of $7.4 million.